Inherited Metabolic Disorders have their origin in specific enzymatic
deficiencies, which affect a given metabolic pathway, leading to the
accumulation of substrates - often toxic - and to reduced (or zero)
production of a biologically important product. The enzyme deficit is
the consequence of mutations in one or more genes coding for the
respective metabolic step.
In short, when there is a metabolic error, some reactions at the enzymatic level do not occur with the proper efficiency. This way, the compounds before the reaction accumulate and the later ones are not synthesized correctly.
The Inherited Metabolic Disorders covered in our site are diagnosed through the neonatal heel prick or Guthrie test.
Our presentation (pdf):
♦ METABOLIC RARE DISEASES TREATMENT ♦
Aminoacidopathies (and organic acidurias) include inherited diseases of the metabolism of
amino acids in different metabolic steps. These pathologies are characterized by signs and
symptoms of acute and progressive intoxication due to accumulation of toxic metabolites
upstream the enzyme block. Long-term treatment consists essentially at removing the
toxic product from the diet, which in practice translates into a protein restricted diet
Why are amino acid formulas restricted in a given amino acid (or groups of amino acids) essential in these pathologies? Because these formulas guarantee an appropriate formation of proteins, indispensable for growth, and that otherwise would not be obtained naturally, due to the toxicity associated with the respective pathology.
Organic acidurias are characterized by the accumulation in blood and urine of compounds derived from intermediate metabolism, which have a markedly acidic pH. These acids undergo conjugation in vivo with carnitine, either for later metabolization or to facilitate their excretion (via urine), giving rise to the respective acylcarnitins.
Urea Cycle Diseases (DCU) are caused by an enzyme deficit in one of the six enzymes normally involved in the metabolic cycle of protein nitrogen excretion, which results in an elevated concentration of ammonia in the blood (hyperammonaemia) - toxic compound, especially at the neurological level. If treatment is not carried out on time and at long term, patients with DCU may suffer from variable encephalopathy (including psychiatric manifestations) and liver dysfunction. Dietary treatment involves a hypoprotein diet, supplemented in a mixture of essential amino acids, as well as in arginine.
Bile Acid Synthesis Disorders occur due to defects in enzymes involved in the transformation of cholesterol into primary bile acids. The two main types of disorders are due to the deficiency of the 3β-HSD enzyme or the Δ4-3-oxoR enzyme, responsible for the absence of primary bile acid synthesis (cholic acid and chenodeoxycholic acid), and consequent anomalous accumulation of toxic metabolites that cause liver damage. If the pathology is not treated properly, the patient may progress to a scenario of liver failure and neurological disease. The recommended therapy is oral bile acid therapy, through replacement of cholic acid.